China’s BRL Gears Up For First UCAR-T Trial In Leukemia/Lymphoma

Country Becoming Global Leader In UCAR-Ts

 
• By Xu Hu
  
CAR-T cells
China's BRL Medicine is advancing an in-house pipeline of universal CAR-T therapies. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Interviews

More from China